Victoza vs Saxenda: Same Drug, Two Very Different Jobs

Victoza vs Saxenda is the same medicine under two brands. Both are liraglutide, a daily GLP-1 shot from Novo Nordisk. Victoza is FDA-approved for type 2 diabetes (up to 1.8 mg a day). Saxenda is FDA-approved for weight loss (up to 3 mg a day). Saxenda's brand ends with last wholesaler shipments in late January 2027.

The real choice is which labeled use you need, what your plan covers, and whether a weekly GLP-1 is a better next step. Below: doses, labels, 2026 prices, generics and when to ask about a weekly option.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access and cost.

Victoza vs Saxenda at a glance

Sources for every row are in the sections below. Prices checked November 5, 2026.

Saxenda's label goes higher because it was studied for weight loss. Victoza stops at 1.8 mg and adds a heart-risk indication for adults with type 2 diabetes and established heart disease. Diagnosis, coverage and budget decide the fit.

If you're weighing daily liraglutide against a weekly shot, The RX Index's Find My GLP-1 Path tool is free, takes about 2 minutes and needs no signup.

Are Victoza and Saxenda the same drug?

Yes. Both pens contain liraglutide at 6 mg per mL. They are branded, dosed and labeled for different jobs.

• Victoza is the diabetes brand. Its label covers blood sugar control in type 2 diabetes for adults and children 10 and older, and lowering the risk of major heart events in adults who already have type 2 diabetes and cardiovascular disease.
• Saxenda is the weight-loss brand. Its label covers weight reduction and long-term weight maintenance, with diet and exercise, in adults with obesity or overweight plus a weight-related condition, and in teens 12 and older who weigh more than 60 kg and have obesity.

Do not take both at once. Each label says not to combine liraglutide products, and Saxenda also says not to combine it with any other GLP-1. Your prescriber decides.

For weekly semaglutide comparisons, see Victoza vs Ozempic and Saxenda vs Ozempic. The GLP-1 FDA indications chart maps every approved use.

How do the doses differ?

Both start at 0.6 mg once a day. Victoza then steps to 1.2 mg, and may go to 1.8 mg. Saxenda keeps climbing weekly through 1.2, 1.8 and 2.4 mg to a 3 mg maintenance dose.

These are label facts, not DIY dosing instructions. Injection sites (abdomen, thigh or upper arm) and missed-dose rules are in each Instructions for Use. A clinician decides how to start, stop or switch.

Which works better for weight loss?

Saxenda is the liraglutide brand studied and approved for weight loss. Victoza is not FDA-approved for weight management, even though the same molecule can reduce appetite as a side effect of diabetes treatment.

On Saxenda's own label, after 56 weeks:

If the question is whether a weekly GLP-1 beats Saxenda's dose, the closest head-to-head is STEP 8. Adults without diabetes on weekly semaglutide 2.4 mg (the Wegovy dose) lost 15.8% of body weight over 68 weeks, versus 6.4% on daily liraglutide 3.0 mg (the Saxenda dose). From a ~230 lb start, that's about 36 lb vs about 15 lb (our math). Stomach side effects were common on both. STEP 8 did not test Victoza's diabetes doses.

Victoza vs Saxenda for type 2 diabetes

Victoza is the diabetes product. In the LEADER trial on its label, adults with type 2 diabetes and high heart risk had a first major adverse heart event in 13.0% on Victoza vs 14.9% on placebo (hazard ratio 0.87). Saxenda is not approved to treat type 2 diabetes, and its label says pediatric type 2 diabetes use has not been established.

If blood sugar and heart risk are the main goals, ask about Victoza, a Victoza generic, or a weekly diabetes GLP-1 such as Ozempic. See our best GLP-1 for diabetes guide.

Side effects and safety

Both labels carry the same boxed warning: in rodents, liraglutide caused thyroid C-cell tumors, and it is unknown whether that happens in people. Do not use Victoza or Saxenda if you or a family member has had medullary thyroid cancer (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Common stomach side effects show up on both labels. The percentages below come from each drug's own placebo-controlled trials, in different populations, so they are not head-to-head:

Both labels also warn about pancreatitis, gallbladder problems, kidney injury from fluid loss, severe stomach reactions, allergic reactions, and low blood sugar with insulin or a sulfonylurea. Saxenda adds a heart-rate warning and says to stop if pregnancy is recognized. Victoza's pregnancy wording is benefit-vs-risk with the clinician.

Get medical help for severe belly pain that will not go away, an allergic reaction, or a neck lump or swelling.

Victoza vs Saxenda cost (as of November 5, 2026)

At list price, Saxenda costs more per month because the maintenance dose is higher and the pack is five pens. Lined up to about 30 days:

Novo says most people with insurance do not pay list price. Cash prices vary by pharmacy. Full breakdowns: Victoza cost and Saxenda cost.

Brand vs generic cash prices we verified today

Generic Victoza-strength liraglutide is far cheaper per box than brand Victoza. Saxenda-strength generic is about half of brand list at Cost Plus. Ask for the right pack: 2- or 3-pen boxes are diabetes (Victoza) generics; the 5-pen box is the weight-management (Saxenda) generic.

Saxenda has had no manufacturer savings offer for new patients since June 30, 2023. Victoza.com says it is covered by most major plans, including Medicare and Medicaid (Novo's claim). Your plan sets the copay.

A year of brand Saxenda at list is about $16,400 (our math). A year of Wegovy pens at NovoCare's $349 cash price is $4,537 for 13 four-week fills. That gap is why many Saxenda patients ask about a weekly switch before January 2027.

Is Saxenda being discontinued? What about Victoza?

Saxenda brand: yes. Novo Nordisk says last shipments to wholesalers are in late January 2027, and that the decision is not about safety or quality. FDA's shortage database, checked November 5, 2026, lists Saxenda as limited availability until discontinuation in January 2027. Novo customer care: 1-800-727-6500.

Victoza brand: not discontinued in the US. FDA lists brand Victoza as limited availability from a shipping delay (duration "TBD"). Victoza-strength generics from several makers are listed as available.

Generics: Victoza generics have been available since Teva's authorized generic in June 2024, with Hikma and others following. Saxenda generics have FDA approvals from Teva, Biocon and Orbicular (Cipla); Teva's 5-pen product is on FDA's discontinuation list (posted May 14, 2026). Ask which maker your pharmacy stocks.

Supply tracker: GLP-1 shortage tracker.

Insurance: diabetes coverage vs weight-loss coverage

Plans often treat these brands differently even though the molecule is the same.

• Victoza is a diabetes drug. Novo says most major plans, including Medicare and Medicaid, cover it. Prior authorization is still common.
• Saxenda is a weight-loss drug. Many plans exclude weight-loss medicines entirely, or prefer a generic or a weekly option. See Saxenda insurance coverage, Does Cigna cover Saxenda?, Does Blue Cross Blue Shield cover Saxenda? and Does Aetna cover Saxenda?.
• Medicare: Part D can cover Victoza for diabetes under your plan's rules. Drugs used only for weight loss are generally not covered. The Medicare GLP-1 Bridge ($50 a month from July 1, 2026) lists Foundayo, Wegovy and Zepbound KwikPen only — not Saxenda, Victoza or generic liraglutide. Details: Medicare GLP-1 Bridge guide.

If you want help checking coverage for a weekly brand-name GLP-1 (Ozempic, Wegovy or Zepbound pens), Ro's free insurance checker looks those up and Ro says its team handles the paperwork. Ro says Medicaid and some other government-funded plans are not eligible for treatment on Ro.

When Victoza fits, when Saxenda fits, when to step up

Do not stop, start or convert doses on your own. Liraglutide brands are not interchangeable milligram-for-milligram with weekly GLP-1s, and your clinician sets the plan.

Weekly options if you are ready to switch

In cash, as of November 5, 2026:

Ro membership is separate: $39 the first month, then $74 a month on the 12-month prepaid plan ($888 a year) up to $149 month-to-month. Medicine is billed on top. See Ro GLP-1 cost, Wegovy vs Zepbound vs Saxenda, best Saxenda alternatives and cheapest Wegovy without insurance.

What we actually verified

• Read the Victoza prescribing information (revised October 2025) and the Saxenda prescribing information (revised February 2026) for uses, doses, warnings, side-effect tables and Saxenda's weight results.
• Opened NovoCare's Saxenda page for the January 2027 discontinuation notice and the closed savings offer.
• Checked FDA's liraglutide drug-shortage records (brand Victoza, brand Saxenda, and generics).
• Opened Novo Nordisk's Victoza and Saxenda list-price pages.
• Pulled Mark Cuban Cost Plus Drugs API prices and stock for Victoza-strength and Saxenda-strength generic liraglutide.
• Confirmed Teva and Hikma Victoza-generic launch announcements, and Drugs@FDA records for Saxenda generics.
• Read the STEP 8 abstract on PubMed and Wegovy's self-pay page.
• Opened Ro's pricing, insurance and insurance-checker pages.
• Confirmed Victoza.com's coverage wording in a headless browser.
• Did the pack-to-day, per-28-day, yearly and pound-conversion math ourselves.

All checks were done on November 5, 2026. We did not get insurer quotes, pharmacy counter quotes or discount-card prices. Prices and stock change, so confirm before you fill.

Frequently asked questions

Is Victoza the same as Saxenda?

They contain the same active drug, liraglutide. Victoza is branded and dosed for type 2 diabetes (up to 1.8 mg daily). Saxenda is branded and dosed for weight loss (up to 3 mg daily). Do not take both together.

Which is stronger, Victoza or Saxenda?

Saxenda's maintenance dose (3 mg) is higher than Victoza's top dose (1.8 mg). "Stronger" still depends on the goal: Saxenda was studied for weight loss at 3 mg; Victoza for blood sugar and heart outcomes at diabetes doses.

Is Saxenda being discontinued?

Yes. Novo Nordisk says last shipments to wholesalers are in late January 2027. FDA lists the brand as available until then, with limited availability. Generic liraglutide 3 mg from other makers may still be an option; ask your pharmacist which manufacturer they have.

Is Victoza being discontinued?

Not in the United States, based on FDA's shortage database checked November 5, 2026. Brand Victoza is listed as limited availability because of a shipping delay. Generics are listed as available.

How much do Victoza and Saxenda cost?

As of November 5, 2026, Victoza lists at $543.51 for 2 pens or $815.27 for 3 pens. Saxenda lists at $1,349.02 for 5 pens. Generic liraglutide at Cost Plus was $97.80 (2-pen Victoza strength, out of stock), $139.20 (3-pen, in stock) and $716.50 (5-pen Saxenda strength, in stock), before shipping.

Can I switch from Saxenda to Victoza, or the other way?

Only with your prescriber. The labeled uses and doses differ, and each label warns against combining liraglutide products. A switch is a clinical decision, not a pharmacy substitution.

Is there a generic for Victoza and Saxenda?

Yes for both. Victoza-strength generics (2- and 3-pen packs) have been available since 2024. Saxenda-strength generics (5-pen packs) have FDA approvals from Teva, Biocon and Orbicular/Cipla; Teva's version is on FDA's discontinuation list, so confirm the maker at the pharmacy.

Should I move to a weekly GLP-1 instead?

Often worth asking if you are on Saxenda before the brand ends, paying cash near list price, or want fewer injections. In STEP 8, the Wegovy dose of semaglutide outperformed Saxenda's dose for weight loss. Coverage and history still decide. Ro posts weekly cash prices and a free coverage check for certain pens.

Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.

Sources

All checked November 5, 2026 unless noted.

• Novo Nordisk, Victoza Prescribing Information, revised 10/2025
• Novo Nordisk, Saxenda Prescribing Information, revised 02/2026
• Novo Nordisk, Victoza pricing (list price/WAC) and Saxenda pricing (list price/WAC)
• NovoCare, Saxenda: discontinuation notice and savings offer status
• Victoza.com, Coverage and reimbursement FAQ
• FDA, Drug shortage API: liraglutide
• FDA, Drugs@FDA: Teva ANDA 214568, Biocon ANDA 217063, Orbicular ANDA 217234
• Teva, Launch of authorized generic of Victoza, June 24, 2024
• Hikma, FDA approval and launch of generic Victoza, 26 December 2024
• Mark Cuban Cost Plus Drugs API: Victoza-strength generic (NDC search 00480-3667-20 and 00480-3667-22) and Saxenda-strength generic product page
• Rubino DM, et al. STEP 8 randomized clinical trial, JAMA, 2022
• Novo Nordisk, Save on Wegovy
• Medicare.gov, Weight loss drugs and Medicare GLP-1 Bridge PDF
• Ro, Weight loss pricing, GLP-1 insurance checker and Insurance